Quarterly report · Q1

Period2024-01-01 → 2024-03-31
Filed2024-05-10
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥2.7bn2024-01-01 → 2024-03-31StandaloneNet sales
Revenue¥11.0bn2023-01-01 → 2023-12-31StandaloneNet sales (5-year summary)
Revenue¥2.4bn2023-01-01 → 2023-03-31StandaloneNet sales
Operating income¥1.3bn2024-01-01 → 2024-03-31StandaloneOperating income
Operating income¥1.0bn2023-01-01 → 2023-03-31StandaloneOperating income
Ordinary income¥1.4bn2024-01-01 → 2024-03-31StandaloneOrdinary income
Ordinary income¥5.3bn2023-01-01 → 2023-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥1.1bn2023-01-01 → 2023-03-31StandaloneOrdinary income
Profit before tax¥1.4bn2024-01-01 → 2024-03-31StandaloneIncome before income taxes
Profit before tax¥1.1bn2023-01-01 → 2023-03-31StandaloneIncome before income taxes
Net income¥970m2024-01-01 → 2024-03-31StandaloneProfit loss
Net income¥3.8bn2023-01-01 → 2023-12-31StandaloneNet income loss (5-year summary)
Net income¥746m2023-01-01 → 2023-03-31StandaloneProfit loss
Total assets¥18.5bnat 2024-03-31StandaloneAssets
Total assets¥18.9bnat 2023-12-31StandaloneAssets
Total assets¥16.4bnat 2023-03-31StandaloneTotal assets (5-year summary)
Total liabilities¥3.2bnat 2024-03-31StandaloneLiabilities
Total liabilities¥3.3bnat 2023-12-31StandaloneLiabilities
Net assets / equity¥15.3bnat 2024-03-31StandaloneNet assets
Net assets / equity¥15.7bnat 2023-12-31StandaloneNet assets
Net assets / equity¥13.2bnat 2023-03-31StandaloneNet assets (5-year summary)
Cash and deposits¥9.8bnat 2024-03-31StandaloneCash and deposits
Cash and deposits¥10.1bnat 2023-12-31StandaloneCash and deposits
EPS (basic)¥101.932024-01-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥396.272023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥78.372023-01-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥2002023-01-01 → 2023-12-31StandaloneDividend paid per share (5-year summary)
Equity ratio82.6%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio82.7%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio80.4%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Shares issued9,525,000at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued9,525,000at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued9,525,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 256
ItemContextValueUnit
Description of fact that companys business comprises single segmentCurrentYTDDuration_NonConsolidatedMember
Original text (Japanese)当社は、体外診断用医薬品事業の単一セグメントであるため、記載を省略しております。
Notes revenue recognition quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes significant events after reporting period quarterly financial statements (text)CurrentYTDDurationText · Plus
Other information financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2023-12-31pass rounding
balance sheet identitynon_consolidated 2024-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-03-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass